about
GATE: a simulation toolkit for PET and SPECT.Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancerSimulating the Impact of the Natural Radiation Background on Bacterial Systems: Implications for Very Low Radiation Biological Experiments.Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy.Innovative in silico approaches to address avian flu using grid technology.A review of the use and potential of the GATE Monte Carlo simulation code for radiation therapy and dosimetry applications.Validation of a dose deposited by low-energy photons using GATE/GEANT4.The Healthgrid White Paper.Track structure modeling in liquid water: A review of the Geant4-DNA very low energy extension of the Geant4 Monte Carlo simulation toolkit.[¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models.Internal dosimetry through GATE simulations of preclinical radiotherapy using a melanin-targeting ligand.Grid-enabled sentinel network for cancer surveillance.Sentinel e-health network on grid: developments and challenges.Validation of the GATE Monte Carlo simulation platform for modelling a CsI(Tl) scintillation camera dedicated to small-animal imaging.In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule.Comparison of GATE/GEANT4 with EGSnrc and MCNP for electron dose calculations at energies between 15 keV and 20 MeV.Coupling of Geant4-DNA physics models into the GATE Monte Carlo platform: Evaluation of radiation-induced damage for clinical and preclinical radiation therapy beamsSimulating radial dose of ion tracks in liquid water simulated with Geant4-DNA: A comparative studyGATE simulation for medical physics with genius web portalGATE V6: a major enhancement of the GATE simulation platform enabling modelling of CT and radiotherapy
P50
Q31130081-7BD020AF-71B0-459B-8352-AEDC34A303FCQ33591800-217B0DAA-328D-4208-8842-9F003E083B30Q36194081-531B81DD-FE42-42B2-9152-644B4AB04CD8Q37505658-9E279B7E-812B-4DD4-AFED-3600F17BF0D6Q37516055-3AD56AC9-8345-4826-BB82-A5D6EB3F088BQ38216063-6AFC8658-2ED9-4488-A3E5-76C16E3EA324Q38442512-2D2377D9-125D-460F-84FD-F9F3A094A310Q38457717-10E7B293-E0DC-42D0-BB2E-C096E518FD1BQ38664997-234E35BD-1DD9-465F-99DB-E32ED665EB68Q38924577-B3B47CAF-BE30-4CD9-B387-B00BFA231A49Q40183123-B887FEAC-8B93-47E4-8D9F-B18D08B305DEQ42627391-B01A9B2B-41C6-40E8-82F3-254E412AEA47Q42663844-C6335C43-E7B3-4B7C-A2A7-1F6A9D9DE804Q51636838-32C4A095-B478-4DAA-B46E-3E5AF4747C12Q53120428-413C7B6E-F58E-4985-8CA1-565F7776F3E6Q53249725-4B2A02A0-6769-49FC-ABCD-5A29A776E8A6Q61509358-72C1F674-90EE-4434-831A-4A29D34C3EA0Q61509408-3E6414AE-E92C-43A7-8B90-B1311A10CC6AQ79845231-0FB83647-61E5-449F-A65B-B670B202C0CBQ83239861-BD02115E-8689-40F7-8F77-F01E979F1D12
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lydia Maigne
@ast
Lydia Maigne
@en
Lydia Maigne
@es
Lydia Maigne
@nl
type
label
Lydia Maigne
@ast
Lydia Maigne
@en
Lydia Maigne
@es
Lydia Maigne
@nl
prefLabel
Lydia Maigne
@ast
Lydia Maigne
@en
Lydia Maigne
@es
Lydia Maigne
@nl
P106
P21
P31
P496
0000-0002-0414-8462